A. Omma Et Al. , "Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial," Human Vaccines and Immunotherapeutics , vol.18, no.6, 2022
Omma, A. Et Al. 2022. Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial. Human Vaccines and Immunotherapeutics , vol.18, no.6 .
Omma, A., Batirel, A., Aydin, M., Yilmaz Karadag, F., Erden, A., KÜÇÜKŞAHİN, O., ... Armagan, B.(2022). Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial. Human Vaccines and Immunotherapeutics , vol.18, no.6.
Omma, Ahmet Et Al. "Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial," Human Vaccines and Immunotherapeutics , vol.18, no.6, 2022
Omma, Ahmet Et Al. "Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial." Human Vaccines and Immunotherapeutics , vol.18, no.6, 2022
Omma, A. Et Al. (2022) . "Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial." Human Vaccines and Immunotherapeutics , vol.18, no.6.
@article{article, author={Ahmet Omma Et Al. }, title={Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial}, journal={Human Vaccines and Immunotherapeutics}, year=2022}